Advertisement

Human immunodeficiency virus and infertility treatment: an Ethics Committee opinion

  • Ethics Committee of the American Society for Reproductive Medicine
      Human Immunodeficiency Virus is a serious but manageable chronic disease that affects persons of reproductive age, many of whom express a desire for biological parenthood. This document is a revision of the original document of the same name, last published in 2015 (Fertil Steril 2015;104:e1–8).

      Key Words

      To read this article in full you will need to make a payment

      References

        • Beyeza-Kashesya J.
        • Ekstrom A.M.
        • Kaharuza F.
        • Mirembe F.
        • Neema S.
        • Kulane A.
        My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in Uganda.
        BMC Public Health. 2010; 10: 247
        • Mantell J.E.
        • Exner T.M.
        • Cooper D.
        • Bai D.
        • Leu C.S.
        • Hoffman S.
        • et al.
        Pregnancy intent among a sample of recently diagnosed HIV-positive women and men practicing unprotected sex in Cape Town, South Africa.
        J Acquir Immune Defic Syndr. 2014; 67: S202-S209
        • Ethics Committee of the American Fertility Society
        Ethical considerations of assisted reproductive technologies.
        Fertil Steril. 1994; 62: 85s
        • Anderson D.J.
        Assisted reproduction for couples infected with the human immunodeficiency virus type.
        Fertil Steril. 1999; 72: 592-594
        • Politch J.A.
        • Anderson D.J.
        Use of assisted reproductive technology to prevent the transmission of HIV-1 in HIV-1 discordant couples desiring children.
        in: Arici A. Immunology and allergy clinics of North America. W.B. Saunders, Philadelphia2002: 663-679
        • Sauer M.
        Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review.
        Reprod Biomed Online. 2005; 10: 135-140
        • HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
        Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States.
        (Available at:)
        • Lundgren J.D.
        • Babiker A.G.
        • Gordin F.
        • Emery S.
        • Grund B.
        • et al.
        • INSIGHT START Study Group
        Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
        N Engl J Med. 2015; 373: 795-807
        • Centers for Disease Control and Prevention
        Achievements in public health. Reduction in perinatal transmission of HIV infection—United States, 1985– 2005.
        MMWR Morb Mortal Wkly Rep. 2006; 55: 592-597
        • Connor E.M.
        • Sperling R.S.
        • Gelber R.
        • Kiselev P.
        • Scott G.
        • O'Sullivan M.J.
        • et al.
        Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.
        N Engl J Med. 1994; 331: 1173-1180
        • Graham W.J.
        • Newell M.L.
        Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality.
        Lancet. 1999; 353: 836-839
        • Lindegren M.L.
        • Byers Jr., R.H.
        • Thomas P.
        • Davis S.F.
        • Caldwell B.
        • Rogers M.
        • et al.
        Trends in perinatal transmission of HIV/AIDS in the United States.
        JAMA. 1999; 282: 531-538
        • Brooks J.T.
        • Kawwass J.F.
        • Smith D.K.
        • Kissin D.M.
        • Lampe M.
        • Haddad L.B.
        • et al.
        Effects of Antiretroviral Therapy to Prevent HIV Transmission to Women in Couples Attempting Conception When the Man Has HIV Infection — United States, 2017.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 859-860
        • Kawwass J.F.
        • Smith D.K.
        • Kissin D.M.
        • Haddad L.B.
        • Boulet S.L.
        • Sunderam S.
        • Jamieson D.J.
        Strategies for Preventing HIV Infection Among HIV-Uninfected Women Attempting Conception with HIV-Infected Men - United States.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 554-557
        • Kawwass J.F.
        • Haddad L.B.
        • Anderson J.R.
        • Jamieson D.J.
        Access to Fertility Treatment for Mixed-Status Couples With Human Immunodeficiency Virus.
        Obstet Gynecol. 2018; 131: 875-878
        • Practice Committee of American Society for Reproductive Medicine
        Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion.
        Fertil Steril. 2020; 114: 1158-1164
        • Del Romero J
        • Baza M.B.
        • Río I.
        • Jerónimo A.
        • Vera M.
        • Hernando V.
        • Rodríguez C.
        • et al.
        Natural conception in HIV-serodiscordant couples with the infected partner in suppressive antiretroviral therapy: A prospective cohort study.
        Medicine (Baltimore). 2016; 95: e4398
        • Givens M.
        • Dotters-Katz S.K.
        • Stringer E.
        • Rahangdale L.
        • Kuller J.A.
        Minimizing the Risk of Perinatal Human Immunodeficiency Virus Transmission.
        Obstet Gynecol Surv. 2018; 73: 423-432
        • International Perinatal HIV Group
        The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies.
        N Engl J Med. 1999; 340: 977-987
        • van Vliet A.
        • van Roosmalen J.
        Worldwide prevention of vertical human immunodeficiency virus (HIV) transmission.
        Obstet Gynecol Surv. 1997; 52: 301-309
        • Stringer J.S.
        • Rouse D.J.
        • Goldenberg R.L.
        Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restraint.
        JAMA. 1999; 281: 1946-1949
        • Mujugira A.
        • Celum C.
        • Coombs R.W.
        • Campbell J.D.
        • Ndase P.
        • Ronald A.
        • et al.
        HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
        J Acquir Immune Defic Syndr. 2016; 72: 579-584
        • Irwin K.L.
        • Moorman A.C.
        • O'Sullivan M.J.
        • Sperling R.
        • Koestler M.E.
        • Soto I.
        • et al.
        Influence of human immunodeficiency virus infection on pelvic inflammatory disease.
        Obstet Gynecol. 2000; 95: 525-534
        • Clark R.A.
        • Mulligan K.
        • Stamenovic E.
        • Chang B.
        • Watts H.
        • Andersen J.
        • et al.
        Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies.
        J Infect Dis. 2001; 184: 1325-1327
        • Garrido N.
        • Meseguer M.
        • Remohí J.
        • Simoon C.
        • Pellicer A.
        Semen characteristics in human immunodeficiency virus (HIV)-and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing.
        Hum Reprod. 2005; 20: 1028-1034
        • Dulioust E.
        • Du A.L.
        • Costagliola D.
        • Guibert J.
        • Kunstmann J.M.
        • Heard I.
        • et al.
        Semen alterations in HIV-1 infected men.
        Hum Reprod. 2002; 17: 2112-2118
        • Cardona-Maya W.
        • Velilla P.
        • Montoya C.J.
        • Cadavid A.
        • Rugeles M.T.
        Presence of HIV-1 DNA in spermatozoa from HIV-positive patients: changes in the semen parameters.
        Curr HIV Res. 2009; 7: 418-424
        • Frapsauce C.
        • Grabar S.
        • Leruez-Ville M.
        • Launay O.
        • Sogni P.
        • et al.
        Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz?.
        Hum Reprod. 2015; 30: 1797-1806
        • Savasi V.
        • Oneta M.
        • Laoreti A.
        • Parisi F.
        • Parrilla B.
        • Duca P.
        • et al.
        Effects of Antiretroviral Therapy on Sperm DNA Integrity of HIV-1-Infected Men.
        Am J Mens Health. 2018; 12: 1835-1842
        • Baeten J.M.
        • Heffron R.
        • Kidoguchi L.
        • Mugo N.R.
        • Katabira E.
        • Bukusi E.A.
        • et al.
        Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
        PLoS Med. 2016; 13e1002099
        • Pasquier C.
        • Walschaerts M.
        • Raymond S.
        • Moinard N.
        • Saune K.
        • Daudin M.
        • et al.
        Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.
        Basic Clin Androl. 2017; 27: 17
        • Liuzzi G.
        • Chirianni A.
        • Clementi M.
        • Bagnarelli P.
        • Valenza A.
        • Cataldo P.T.
        • et al.
        Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study.
        AIDS. 1996; 10: F51-F56
        • Agboghoroma C.O.
        • Giwa-Osagie OF
        Management of infertility in HIV infected couples: a review.
        Afr J Reprod Health. 2012; 16: 13-20
        • AIDSinfo, National Institutes of Health
        Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.
        (Available at) (last accessed 10-30-19)
        • Mofenson L.M.
        • Baggaley R.C.
        • Mameletzis I.
        Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.
        AIDS. 2017; 31: 213-232
        • Nachega J.B.
        • Uthman O.A.
        • Mofenson L.M.
        • Anderson J.R.
        • Kanters S.
        • Renaud F.
        • et al.
        Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
        J Acquir Immune Defic Syndr. 2017; 76: 1-12
        • AIDSinfo, National Institutes of Health
        Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.
        (Accessible at) (last accessed 10/30/19)
        • Liao C.
        • Wahab M.
        • Anderson J.
        • Coleman J.S.
        Reclaiming fertility awareness methods to inform timed intercourse for HIV serodiscordant couples attempting to conceive.
        J Int AIDS Soc. 2015; 18: 19447
        • Mandelbrot L.
        • Heard I.
        • Henrion-Geeant E.
        • Henrion R.
        Natural conception in HIV-negative women with HIV-infected partners.
        Lancet. 1997; 349: 850-851
        • Cohen M.S.
        • Chen Y.Q.
        • McCauley M.
        • Gamble T.
        • Hosseinipour M.C.
        • Kumarasamy N.
        • et al.
        Prevention of HIV-1 infection with early antiretroviral therapy.
        N Engl J Med. 2011; 365: 493-505
        • Quinn T.C.
        • Wawer M.J.
        • Sewankambo N.
        • Serwadda D.
        • Li C.
        • Wabwire-Mangen F.
        • et al.
        Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.
        N Engl J Med. 2000; 342: 921-929
        • Jindal S.K.
        • Rawlins R.G.
        • Muller C.H.
        • Drobnis E.Z.
        Guidelines for risk reduction when handling gametes from infectious patients seeking assisted reproductive technologies.
        Reprod Biomed Online. 2016; 33: 121-130
        • US Public Health Service
        Prexposure prophylaxis for the prevention of HIV infection in the united states- 2017 update: a clinical practice guideline.
        (Available at) (last accessed 10/31/19)
        • Kambin S.
        • Batzer F.
        Assisted reproductive technology in HIV serodiscordant couples.
        Sex Reprod Menopause. 2004; 2: 92-100
        • Bujan L.
        • Hollander L.
        • Coudert M.
        • Gilling-Smith C.
        • Vucetich A.
        • Guibert J.
        • et al.
        Safety and efficacy of sperm washing in HIV-1 serodiscordant couples where the male is infected: results from the European CREAThE network.
        AIDS. 2007; 21: 1909-1914
        • Zamora M.J.
        • Obradors A.
        • Woodward B.
        • Vernaeve V.
        • Vassena R.
        Semen residual viral load and reproductive outcomes in HIV-infected men undergoing ICSI after extended semen preparation.
        Reprod Biomed Online. 2016; 32: 584-590
        • Inoue O.
        • Kuji N.
        • Ito H.
        • Yamada M.
        • Hamatani T.
        • Oyadomari A.
        • et al.
        Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples.
        Asian J Androl. 2017; 19: 208-213
        • Zafer M.
        • Horvath H.
        • Mmeje O.
        • van der Poel S.
        • Semprini A.E.
        • Rutherford G.
        • et al.
        Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: a systematic review and meta-analysis.
        Fertil Steril. 2016; 105: 645-655
        • Centers for Disease Control and Prevention
        Morbidity and Mortality Weekly Report: Strategies for Preventing HIV Infection Among HIV-Uninfected Women Attempting Conception with HIV-Infected Men — United States.
        (Accessible at) (last accessed 10/31/19)
        • AIDSinfo, US Department of Health and Human Services
        Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.
        (Accessible at) (last accessed 10/31/19)
        • Sauer M.V.
        • Wang J.G.
        • Douglas N.C.
        • Nakhuda G.S.
        • Vardhana P.
        • Jovanovic V.
        • et al.
        Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection.
        Fertil Steril. 2009; 91: 2455-2460
        • Peckham C.
        • Newell M.L.
        Preventing vertical transmission of HIV infection.
        N Engl J Med. 2000; 343: 1036-1037
        • Cito G.
        • Coccia M.E.
        • Fucci R.
        • Picone R.
        • Cocci A.
        • Russo G.I.
        • et al.
        Influence of male human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection on the reproductive outcomes in serodiscordant couples: a case-control study.
        Andrology. 2019; 7: 852-858
        • Stora C.
        • Epelboin S.
        • Devouche E.
        • Matheron S.
        • Epelboin L.
        • Yazbeck C.
        • et al.
        Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.
        Fertil Steril. 2016; 105: 1193-1201
        • Heffron R.
        • Ngure K.
        • Velloza J.
        • Kiptinness C.
        • Quame-Amalgo J.
        • Oluch L.
        • et al.
        Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.
        J Int AIDS Soc. 2019; 22e25261
        • State of California
        SB-159 HIV: preexposure and postexposure prophylaxis.
        (Available at)
        • Jaumdally S.Z.
        • Liebenberg L.J.P.
        • Gumbi P.P.
        • Little F.
        • Jaspan H.B.
        • Gamieldien H.
        • et al.
        Partner HIV Serostatus Impacts Viral Load, Genital HIV Shedding, and Immune Activation in HIV-Infected Individuals.
        J Acquir Immune Defic Syndr. 2019; 82: 51-60
        • Vankerkem P.
        • Manigart Y.
        • Delvigne A.
        • Ameye L.
        • Konopnicki D.
        • Shaw-Jackson C.
        • et al.
        In vitro fertilization when men, women, or both partners are positive for HIV: a case-control study.
        Arch Gynecol Obstet. 2017; 295: 1493-1507
        • Vernazza P.L.
        • Graf I.
        • Sonnenberg-Schwan U.
        • Geit M.
        • Meurer A.
        Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child.
        AIDS. 2011; 25: 2005-2008
        • Redd A.D.
        • Quinn T.C.
        • Tobian A.R.
        Frequency and implications of HIV superinfection.
        Lancet Infect Dis. 2013; 13: 622-628
        • Committee on Obstetric Practice; HIV Expert Work Group
        ACOG Committee Opinion No. 751: Labor and Delivery Management of Women With Human Immunodeficiency Virus Infection.
        Obstet Gynecol. 2018; 132: e131-e137
        • Fair C.
        • Allen H.
        • Trexler C.
        • D'Angelo L.J.
        Experiences of Young Parents with Perinatally Acquired HIV.
        AIDS Patient Care STDS. 2017; 31: 479-485
        • Centers for Disease Control and Prevention
        Estimated HIV Incidence and Prevalence in the United States 2010–2016.
        (Available at) (last accessed 10/31/19)
        • U.S. Preventive Services
        Taskforce Recommendation Statement. Screening for HIV.
        Ann Intern Med. 2013; 159: 1-36
        • Committee on Obstetric Practice; HIV Expert Work Group
        ACOG Committee Opinion No. 752: Prenatal and Perinatal Human Immunodeficiency Virus Testing.
        Obstet Gynecol. 2018; 132: e138-e142
        • Branson B.M.
        • Handsfield H.H.
        • Lampe M.A.
        • Janssen R.S.
        • Taylor A.W.
        • Lyss S.B.
        • et al.
        Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care setting.
        MMWR Morb Mortal Wkly Rep. 2006; 55: 1-17
      1. Food and Drug Administration; Part 1271–human cells, tissues and cellular and tissue based products; donor screening and testing, and related labeling; interim final rule 5/24/05. Federal Register, vol. 70, no. 100, May 25, 2005, Rules and Regulations.
        (Available at:) (last accessed 10/31/19)
        • Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology
        Recommendations for gamete and embryo donation: a committee opinion.
        Fertil Steril. 2013; 99: 47-62
        • Centers for Disease Control and Prevention
        HIV/AIDS surveillance report, National Center for HIV, STD, and TB Prevention, Divisions of HIV/AIDS Prevention: surveillance of healthcare workers with HIV/AIDS, June 30, 2000.
        (Available at:) (last accessed 10/31/19)
      2. Bragdon v. Abbott (1998); 524 U.S. 624, 118 S. Ct. 2196.

      3. Americans with Disabilities Act of 1990.
        (Available at:) (last accessed 10/31/19)
        • Martins A.
        • Alves S.
        • Chaves C.
        • Canavarro M.C.
        • Pereira M.
        Prevalence and factors associated with fertility desires/intentions among individuals in HIV-serodiscordant relationships: a systematic review of empirical studies.
        J Int AIDS Soc. 2019; 22e25241
        • Thomson K.A.
        • Dhanireddy S.
        • Andrasik M.
        • Hancuch K.
        • Legg L.
        • Keane-Candib J.
        • et al.
        Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA.
        AIDS Care. 2018; 30: 121-129
        • Mekonnen H.
        • Enquselassie F.
        Effect of antiretroviral therapy on changes in the fertility intentions of human immunodeficiency virus-positive women in Addis Ababa, Ethiopia: a prospective follow-up study.
        Epidemiol Health. 2017; 39e2017028
        • Sauer M.V.
        American physicians remain slow to embrace the reproductive needs of human immunodeficiency virus–infected patients.
        Fertil Steril. 2006; 85: 295-297
        • Zakarin Safier L.
        • Sauer M.V.
        Fertility care interventions should be provided as the first line options for HIV+ serodiscordant couples who desire children in settings with affordable access to care, regardless of their fertility status.
        J Int AIDS Soc. 2017; 20: 21294
        • Leech A.A.
        • Bortoletto P.
        • Christiansen C.
        • Drainoni M.L.
        • Linas B.P.
        • Roeca C.
        • et al.
        Assessing access to assisted reproductive services for serodiscordant couples with human immunodeficiency virus infection.
        Fertil Steril. 2018; 109: 473-477
        • Lo C.K.
        • Kennedy V.L.
        • Yudin M.H.
        • Shapiro H.M.
        • Loutfy M.
        Access to fertility services in Canada for HIV-positive individuals and couples: a comparison between 2007 and 2014.
        AIDS Care. 2017; 29: 1433-1436
        • Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology
        Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee Guideline.
        Fertil Steril. 2015; 103: e1-e8
      4. Cal. Health & Safety Code, Sec. 1644.5.
        (Available at:) (Last accessed 10/31/19)
      5. Moore v. Regents of the University of California (1990); 51 Cal. 3d 120.

        • Ethics Committee of the American Society for Reproductive Medicine
        Interests, obligations, and rights in gamete and embryo donation: an Ethics Committee opinion.
        Fertil Steril. 2019; 111: 664-670